A potential world-first cure for hepatitis B, a breakthrough treatment for a rare, life-threatening childhood disease, and a ...

Apogee Therapeutics, Inc.'s APG777 shows promising week-16 efficacy and dosing potential, targeting the AT market. Click for ...

A new analysis highlights the effectiveness of risankizumab in patients with moderate plaque psoriasis and those newly classified as systemic therapy eligible under International Psoriasis Council ...

Dawn foaming dish spray works superbly and most professional cleaners will tell you that you can use it to clean more than ...

Patients with psoriatic arthritis who meet clinical criteria for minimal disease activity also tend to report good disease ...

Within 2 years, I had lower back pain. I stopped working out, thinking rest was the best thing, but my back pain got ...

The National Institutes of Health reports that 80% of the American population will encounter lower back pain at some stage in their lives. The lower back is responsible for stabilizing and supporting ...

JNJ which has outperformed the S&P 500 and other large-cap healthcare peers in H1-2025, now faces a crucial test with Q2 ...